Paper40940933
Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology.
Stefanou E and 3 others. Cancers (Basel), 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology. Papers, record 40940933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940933
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References209
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11209085 | Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. | Science | 2001 | https://conductscience.org/library/papers/11209085 | PubMed |
| 2 | 34986285 | Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34986285 | PubMed |
| 3 | 30074493 | Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis. | Curr Opin Lipidol | 2018 | https://conductscience.org/library/papers/30074493 | PubMed |
| 4 | 29434334 | Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29434334 | PubMed |
| 5 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 6 | 28403786 | Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue. | Curr Med Chem | 2018 | https://conductscience.org/library/papers/28403786 | PubMed |
| 7 | 27554835 | Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion. | Cardiology | 2017 | https://conductscience.org/library/papers/27554835 | PubMed |
| 8 | 29536852 | Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. | Lancet | 2018 | https://conductscience.org/library/papers/29536852 | PubMed |
| 9 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 10 | 32848787 | Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32848787 | PubMed |
| 11 | 24876563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 12 | 34227272 | Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management. | Korean Circ J | 2021 | https://conductscience.org/library/papers/34227272 | PubMed |
| 13 | 32893704 | Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32893704 | PubMed |
| 14 | 27632680 | Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. | Crit Care Med | 2017 | https://conductscience.org/library/papers/27632680 | PubMed |
| 15 | 36636447 | Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer. | JACC CardioOncol | 2022 | https://conductscience.org/library/papers/36636447 | PubMed |
| 16 | 38544797 | Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort study. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38544797 | PubMed |
| 17 | 31988143 | Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/31988143 | PubMed |
| 18 | 29461982 | Immune-mediated Pericarditis With Pericardial Tamponade During Nivolumab Therapy. | J Immunother | 2018 | https://conductscience.org/library/papers/29461982 | PubMed |
| 19 | 32231332 | Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/32231332 | PubMed |
| 20 | 35669482 | Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35669482 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42807136 | Immune checkpoint inhibitor-associated arrhythmias: clinical challenges, artificial intelligence-enhanced monitoring, and management strategies. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42807136 | PubMed |
| 42587686 | Cardiovascular Complications Associated with Uro-Oncology Treatments-A Primer for the Clinician. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587686 | PubMed |
| 42488081 | Immune Checkpoint Inhibitor Associated Myopathy with Concurrent Myocardial Injury: A Retrospective Cohort Study. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42488081 | PubMed |
| 42318367 | Nivolumab-Associated Cardiac Manifestation of Cutaneous T-Cell Lymphoma in a Patient With Concurrent Renal Cell Carcinoma. | Mayo Clin Proc Innov Qual Outcomes | 2026 | https://conductscience.org/library/papers/42318367 | PubMed |
| 42228348 | Clinical spectrum and mechanistic insights into cardiotoxicity from cancer therapies. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42228348 | PubMed |
| 41669678 | Guarding the heart in the era of immunotherapies: insights for cardio-oncology practice. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41669678 | PubMed |
| 41592248 | Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in Patients With Cancer. | J Cardiovasc Pharmacol | 2026 | https://conductscience.org/library/papers/41592248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40940933
GET https://conductscience.org/api/papers/v1/40940933/references?page=2